talipexole has been researched along with Tourette Syndrome in 1 studies
talipexole: dopamine receptor agonist; structure given in first source
Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
Excerpt | Relevance | Reference |
---|---|---|
"Talipexole is a new dopamine autoagonist with putative preferential activity on presynaptic dopamine receptors." | 2.67 | Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial. ( Goetz, CG; Stebbins, GT; Thelen, JA, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goetz, CG | 1 |
Stebbins, GT | 1 |
Thelen, JA | 1 |
1 trial available for talipexole and Tourette Syndrome
Article | Year |
---|---|
Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial.
Topics: Adult; Azepines; Dopamine Agents; Double-Blind Method; Humans; Male; Middle Aged; Neurologic Examina | 1994 |